Terbinafine 1% cream vs. bifonazole 1% cream in the treatment of tinea cruris.
Budimulja
U
U
Department of Dermato-Venereology, School of Medicine, University of Indonesia, RSUPN Hospital, Jakarta.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003877:Dermatitis, Contact / Q000209:etiology; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use*; D009824:Ointments; D010352:Patient Dropouts; D012008:Recurrence; D012867:Skin / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D000077291:Terbinafine; D016896:Treatment Outcome
D000935:Antifungal Agents; D007093:Imidazoles; D009281:Naphthalenes; D009824:Ointments; D000077291:Terbinafine; C036596:bifonazole